Cargando…
Liquiritin Protects Against Cardiac Fibrosis After Myocardial Infarction by Inhibiting CCL5 Expression and the NF-κB Signaling Pathway
PURPOSE: Despite significant advances in interventional treatment, myocardial infarction (MI) and subsequent cardiac fibrosis remain major causes of high mortality worldwide. Liquiritin (LQ) is a flavonoid extract from licorice that possesses a variety of pharmacological properties. However, to our...
Autores principales: | Han, Xue, Yang, Yakun, Zhang, Muqing, Li, Li, Xue, Yucong, Jia, Qingzhong, Wang, Xiangting, Guan, Shengjiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724582/ https://www.ncbi.nlm.nih.gov/pubmed/36483459 http://dx.doi.org/10.2147/DDDT.S386805 |
Ejemplares similares
-
Liquiritin Protects Against Cardiac Fibrosis After Myocardial Fibrosis After Myocardial Infarction by Inhibiting CCL5 Expression and the NF-κB Signaling Pathway [Letter]
por: Idrus, Hasta Handayani, et al.
Publicado: (2023) -
Protective Effects of 6-Gingerol on Cardiotoxicity Induced by Arsenic Trioxide Through AMPK/SIRT1/PGC-1α Signaling Pathway
por: Han, Xue, et al.
Publicado: (2022) -
IL-33 attenuates cardiac remodeling following myocardial infarction via inhibition of the p38 MAPK and NF-κB pathways
por: Yin, Honglei, et al.
Publicado: (2022) -
Potential Effects of CXCL9 and CCL20 on Cardiac Fibrosis in Patients with Myocardial Infarction and Isoproterenol-Treated Rats
por: Lin, Chao-Feng, et al.
Publicado: (2019) -
De novo biosynthesis of liquiritin in Saccharomyces cerevisiae
por: Yin, Yan, et al.
Publicado: (2020)